Package 45802-680-28

Brand: levocetirizine dihydrochloride

Generic: levocetirizine dihydrochloride
NDC Package

Package Facts

Identity

Package NDC 45802-680-28
Digits Only 4580268028
Product NDC 45802-680
Product ID 45802-680_1a939b38-64a2-4238-816d-4c01075e5cbe
Description

148 mL in 1 BOTTLE (45802-680-28)

Marketing

Marketing Status
Marketed Since 2011-11-07
Brand levocetirizine dihydrochloride
Generic levocetirizine dihydrochloride
Sample Package No

Linked Drug Pages (1)

levocetirizine dihydrochloride ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "1a939b38-64a2-4238-816d-4c01075e5cbe", "openfda": {"unii": ["SOD6A38AGA"], "rxcui": ["855168"], "spl_set_id": ["2965ef46-18db-4615-9dce-bfb0f0b3366a"], "manufacturer_name": ["Padagis Israel Pharmaceuticals Ltd"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "148 mL in 1 BOTTLE (45802-680-28)", "package_ndc": "45802-680-28", "marketing_start_date": "20111107"}], "brand_name": "levocetirizine dihydrochloride", "product_id": "45802-680_1a939b38-64a2-4238-816d-4c01075e5cbe", "dosage_form": "SOLUTION", "pharm_class": ["Histamine H1 Receptor Antagonists [MoA]", "Histamine-1 Receptor Antagonist [EPC]"], "product_ndc": "45802-680", "generic_name": "Levocetirizine dihydrochloride", "labeler_name": "Padagis Israel Pharmaceuticals Ltd", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "levocetirizine dihydrochloride", "active_ingredients": [{"name": "LEVOCETIRIZINE DIHYDROCHLORIDE", "strength": ".5 mg/mL"}], "application_number": "ANDA091263", "marketing_category": "ANDA", "marketing_start_date": "20111107", "listing_expiration_date": "20261231"}